News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Methods for Classifying Patients Produce Inaccurate and Inconsistent Results
Scientists Unlock Key to Tamoxifen Resistance
Radiotherapy Regimen Safe for Breast Patients
ICR Receives Environmental Honour
Genetic Abnormalities Predict Prostate Cancer Survival
ICR Selects World's Fastest Supercomputer
Discovery Could Help Refine Advanced Melanoma Treatment
A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published today (Thursday) in Cell*.
Molecules Increase the Effectiveness of Certain Therapies
Genetic Factors Can Increase Leukaemia Risk 7-Fold
DNA Helps Identify Genes that Drive Cancer
Clinical Candidate Selected by AstraZeneca
Drug Can Curb Ewing’s Sarcoma Growth
An early study of the drug figitumumab has found that in some patients it can curb the growth of Ewing’s sarcoma - a cancer which affects mainly teenage boys. The study was led by Dr Johann de Bono, from The Institute of Cancer Research and The Royal Marsden Hospital, and funded by Pfizer, who developed the drug.
